Teruhito Takakuwa Yu Nakagama Mayo Yasugi Toshiki Maeda Kenji Matsuo Ayako Kiritoshi Ryo Deguchi Naohiro Hagawa Wataru Shibata Kazuhiro Oshima Katsumi Yamamoto Kenichiro Uchida Tomohiro Noda Koichi Yamada Tetsuro Nishimura Hiromasa Yamamoto Yasutoshi Kido Masayuki Hino Hiroshi Kakeya Yasumitsu Mizobata
10.2169/internalmedicine.7884-21
Intern Med
2021;60(23):3827-3831.
covid-19 sars-cov-2 neutralizing activity persistent rnaemia rituximab
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/34853259/
COVID-19 SARS-CoV-2
COVID-19 SARS-CoV-2 Case Reports Aged Antibodies, Viral Antibody Formation Humans Male Rituximab / therapeutic use Spike Glycoprotein, Coronavirus Antibodies, Viral Spike Glycoprotein, Coronavirus Rituximab
PMC8710376
34853259
Discrepant Antigen-specific Antibody Responses Causing SARS-CoV-2 Persistence in a Patient Receiving B-cell-targeted Therapy with Rituximab
2021